GlassScriptPhysician profile
Fuad E Zankoul
NPI 1770100489
$6,837.73
in general payments reported to CMS, 2019-2025
6 companies · $5,858 in 2025
The $5,858 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $399 · 2023: $488 · 2024: $92.78 · 2025: $5,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,460 · Travel and Lodging: $1,039 · Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,460.16 |
| Travel and Lodging | $1,038.92 |
| Food and Beverage | $939.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,860.79 | 2022-2025 | Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $589.92 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Konect Resilia |
| Abiomed | $137.46 | 2022 | |
| Boston Scientific Corporation | $126.61 | 2022 | |
| Merck Sharp & Dohme LLC | $108.50 | 2023 | Keytruda |
| True North Surgical INC | $14.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fuad Zankoul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.